A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/17 (2006.01) A61K 39/00 (2006.01) C12N 15/11 (2006.01)
Patent
CA 2745111
The present invention relates to nucleic acids and antibodies against Olfm1-3 and Olfin1-3 protein function in angiogenesis. Angiogenesis-related conditions, such as cancer or wound healing, can be treated by the composition comprising the Olfm1-3 antagonists or agonists, respectively.
La présente invention porte sur des acides nucléiques et des anticorps dirigés contre Olfml-3 et sur la fonction de la protéine Olfml-3 dans l'angiogenèse. Des états apparentés à l'angiogenèse, tels qu'un cancer ou une guérison de plaie, peuvent être traités par la composition comprenant respectivement les antagonistes ou les agonistes d'Olfml-3.
Hammel Philippe
Imhof Beat A.
Miljkovic-Licina Marijana
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Research Development Foundation
LandOfFree
Modulation of olfml-3 mediated angiogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of olfml-3 mediated angiogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of olfml-3 mediated angiogenesis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1590386